Approval summary: erlotinib maintenance therapy of advanced/metastatic non-small cell lung cancer (NSCLC).
暂无分享,去创建一个
R. Pazdur | R. Justice | R. Sridhara | Shenghui Tang | Martin H. Cohen | John R. Johnson | Somesh Chattopadhyay | M. Cohen
暂无分享,去创建一个
R. Pazdur | R. Justice | R. Sridhara | Shenghui Tang | Martin H. Cohen | John R. Johnson | Somesh Chattopadhyay | M. Cohen